Two Malaysian companies have secured the contract to supply the Sinopharm Covid-19 vaccine to this part of the world. Duopharma Biotech Bhd sealed the deal with the Ministry of Health to supply the Sinopharm vaccine in Malaysia. Apex Healthcare Bhd, meanwhile, secured the mandate to supply the Sinopharm vaccine to private clinics and hospitals in Singapore. But the question is, how big a demand is there for the Sinopharm vaccine? Apex Healthcare’s Sinopharm distribution deal is equally challenging.

Source: The Edge Markets September 13, 2021 05:03 UTC